Alder BioPharmaceuticals' Seed Round

Alder BioPharmaceuticals raised a round of funding on September 21, 2004. Investors include WRF Capital.

Alder BioPharmaceuticals identifies, develops and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular and autoimmune and inflammatory disease areas. The com…

Articles about Alder BioPharmaceuticals' Seed Round: